Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1999 May;83(5):577–581. doi: 10.1136/bjo.83.5.577

Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy

K Tsao 1, P Aitken 1, D Johns 1
PMCID: PMC1723036  PMID: 10216058

Abstract

BACKGROUND/AIMS—Leber's hereditary optic neuropathy (LHON) is a mitochondrial DNA mediated disease which causes severe visual deficits. Although expressivity of the disease is 100%, penetrance is variable, and environmental factors may influence risk of becoming symptomatic. The causative relation between cigarette smoking and disease penetrance was examined.
METHODS—The incidence of smoking in 65 age matched family members of one LHON pedigree was retrospectively obtained. Smoking in groups which expressed disease was compared with those which did not. Male subgroups were analysed separately in addition to combined sex groups.
RESULTS—The association between smoking and disease penetrance was significant in all subgroups (p values from p=0.0009 to p=0.0001, 95% confidence intervals). Disease penetrance was higher in males than females. The association was weaker in the male group than combined sex groups (p values from p=0.0146 to p=0.0008, 95% confidence intervals), probably because of elimination of female asymptomatic non-smokers in the comparison groups. The association was strengthened in older age groups and in groups which smoked more heavily.
CONCLUSIONS—Smoking is significantly associated with disease penetrance in this LHON pedigree. Degree of smoking and number of years smoked correlate with increased risk of developing symptoms.



Full Text

The Full Text of this article is available as a PDF (92.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown M. D., Voljavec A. S., Lott M. T., MacDonald I., Wallace D. C. Leber's hereditary optic neuropathy: a model for mitochondrial neurodegenerative diseases. FASEB J. 1992 Jul;6(10):2791–2799. doi: 10.1096/fasebj.6.10.1634041. [DOI] [PubMed] [Google Scholar]
  2. Burns D. M. Cigarettes and cigarette smoking. Clin Chest Med. 1991 Dec;12(4):631–642. [PubMed] [Google Scholar]
  3. Cullom M. E., Heher K. L., Miller N. R., Savino P. J., Johns D. R. Leber's hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. Arch Ophthalmol. 1993 Nov;111(11):1482–1485. doi: 10.1001/archopht.1993.01090110048021. [DOI] [PubMed] [Google Scholar]
  4. Johns D. R. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. N Engl J Med. 1995 Sep 7;333(10):638–644. doi: 10.1056/NEJM199509073331007. [DOI] [PubMed] [Google Scholar]
  5. Kosmorsky G., Johns D. R. Neuro-ophthalmologic manifestations of mitochondrial DNA disorders: chronic progressive external ophthalmoplegia, Kearns-Sayre syndrome, and Leber's hereditary optic neuropathy. Neurol Clin. 1991 Feb;9(1):147–161. [PubMed] [Google Scholar]
  6. Pérez-Stable E. J., Marín G., Marín B. V., Benowitz N. L. Misclassification of smoking status by self-reported cigarette consumption. Am Rev Respir Dis. 1992 Jan;145(1):53–57. doi: 10.1164/ajrccm/145.1.53. [DOI] [PubMed] [Google Scholar]
  7. Shoffner J. M., 4th, Wallace D. C. Oxidative phosphorylation diseases. Disorders of two genomes. Adv Hum Genet. 1990;19:267–330. [PubMed] [Google Scholar]
  8. Volpe N. J., Lessell S. Leber's hereditary optic neuropathy. Int Ophthalmol Clin. 1993 Spring;33(2):153–168. doi: 10.1097/00004397-199303320-00015. [DOI] [PubMed] [Google Scholar]
  9. Wilson J. Cyanide in human disease: a review of clinical and laboratory evidence. Fundam Appl Toxicol. 1983 Sep-Oct;3(5):397–399. doi: 10.1016/s0272-0590(83)80011-6. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES